Literature DB >> 27733939

Max Hirsch (1875-1941): His forgotten fate and his contributions to the founding of modern rheumatology.

Wolfgang Keitel1, Leif Olsson2, Eric L Matteson3.   

Abstract

OBJECTIVE: To elucidate the connections between balneology and rheumatology in the founding period of the discipline of rheumatology, and describe the contributions of Max Hirsch, MD in the formation of professional rheumatology societies.
MATERIAL AND METHODS: Historical documents from the medical history collection of Vogelsang-Gommern, Germany, and original personal documents of the Hirsch family and information from the medical and historical period literature were used in developing this report.
RESULTS: The first efforts at organizing rheumatology as a recognized clinical and academic discipline took place in the 1920s. Many of the first proponents were balneologists who cared for patients with chronic arthritic conditions without the benefit of effective medications. Max Hirsch, MD was a major figure in the development of modern rheumatology as it emerged from the provenance of balneology and orthopedics as a recognized organized medical discipline, contributing to the founding of the German Society for Rheumatology and the International League Against Rheumatism.
CONCLUSION: Max Hirsch made significant contributions to scientific and organized rheumatology in the early days of the discipline. His contributions to the field and his fate as a Jewish physician have only recently come to light.

Entities:  

Keywords:  Max Hirsch; balneology; history of rheumatology

Year:  2016        PMID: 27733939      PMCID: PMC5058447          DOI: 10.5152/eurjrheum.2016.15101

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  2 in total

1.  [Forty years of the German Society for Rheumatology].

Authors:  G A Schoger
Journal:  Z Rheumaforsch       Date:  1967-12

2.  [Max Hirsch founder of rheumatology in Germany: banished and murdered].

Authors:  W Keitel
Journal:  Z Rheumatol       Date:  2014-08       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.